We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DTF
2801
DTF Tax-Free Income 2028 Term Fund
DTF
$81.1M
| $643K | ﹤0.01% |
45,249
| – | – |
|
2802
Quad
QUAD
$525M
| $641K | ﹤0.01% |
197,363
-66,415
| -25% | -$203K |
|
2803
Park-Ohio Holdings
PKOH
$761M
| $639K | ﹤0.01% |
38,519
+2,620
| +7% | +$41.1K |
|
|
ITIC
2804
Investors Title Co
ITIC
$547M
| $638K | ﹤0.01% |
5,262
-1,263
| -19% | -$157K |
|
|
AWH
2805
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $638K | ﹤0.01% |
+11,071
| New | +$739K |
|
|
RPT
2806
Rithm Property Trust
RPT
$93.7M
| $637K | ﹤0.01% |
11,534
-13,659
| -54% | -$667K |
|
|
NAGE
2807
Niagen Bioscience
NAGE
$247M
| $637K | ﹤0.01% |
138,848
+29,849
| +27% | +$134K |
|
|
KIN
2808
DELISTED
Kindred Biosciences, Inc.
KIN
| $636K | ﹤0.01% |
141,593
+15,158
| +12% | +$67.7K |
|
|
MEN
2809
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
| $636K | ﹤0.01% |
58,051
| – | – |
|
2810
Fennec Pharmaceuticals
FENC
$402M
| $633K | ﹤0.01% |
+75,810
| New | +$564K |
|
|
GPX
2811
DELISTED
GP Strategies Corp.
GPX
| $631K | ﹤0.01% |
73,570
+17,850
| +32% | +$128K |
|
|
PROS
2812
DELISTED
ProSight Global, Inc.
PROS
| $631K | ﹤0.01% |
70,839
-18,854
| -21% | -$171K |
|
|
VWTR
2813
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $629K | ﹤0.01% |
74,683
| – | – |
|
2814
AMES National
ATLO
$277M
| $624K | ﹤0.01% |
31,622
-2,454
| -7% | -$48K |
|
2815
Enterprise Products Partners
EPD
$81.7B
| $624K | ﹤0.01% |
34,351
-6,279
| -15% | -$112K |
|
2816
iBio
IBIO
$70M
| $623K | ﹤0.01% |
+561
| New | +$367K |
|
2817
Westwood Holdings Group
WHG
$190M
| $622K | ﹤0.01% |
39,532
-43,843
| -53% | -$834K |
|
2818
INNOVATE Corp
VATE
$165M
| $619K | ﹤0.01% |
+18,546
| New | +$524K |
|
2819
Genie Energy
GNE
$383M
| $618K | ﹤0.01% |
83,940
-30,241
| -26% | -$237K |
|
2820
Funko
FNKO
$328M
| $617K | ﹤0.01% |
106,482
-25,112
| -19% | -$122K |
|
|
SCTL
2821
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $617K | ﹤0.01% |
135,574
-229,048
| -63% | -$1.42M |
|
2822
Ardmore Shipping
ASC
$683M
| $611K | ﹤0.01% |
140,948
-7,927
| -5% | -$42.4K |
|
2823
Aspen Aerogels
ASPN
$518M
| $607K | ﹤0.01% |
+92,253
| New | +$592K |
|
2824
InfuSystem Holdings
INFU
$249M
| $605K | ﹤0.01% |
+52,384
| New | +$602K |
|
2825
Kulicke & Soffa
KLIC
$4.78B
| $605K | ﹤0.01% |
29,034
+4,170
| +17% | +$94.4K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.